Stanozolol-induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype at Presentation.

Background & Aims: The misuse of Anabolic Androgenic Steroids (AAS), including Stanozolol, for performance enhancement has emerged as a significant cause of liver damage. This study aims to elucidate the distinctive hepatotoxicity profiles induced by Stanozolol.

Methods: Eighteen individuals were prospectively evaluated by the Latin American DILI Registry from 2013 to 2023.

Association Between Anthropometric and Hematological Parameters and the Diagnosis of Intestinal Parasitosis in Low-Income Children.

Objective: This study aims to determine the association between anthropometric values and laboratory tests with parasitosis diagnosis and identify diagnostic models for parasitosis without relying on copro-parasitological examinations.

Methods: Data were collected from 1894 children aged 0-14 who attended a medical center for low-income children in Lima, Peru, between 2021 and 2022. Anthropometric data (BMI, weight, height), laboratory data (red blood cells, hemoglobin, platelets, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, eosinophils), and parasitological examination results were analyzed.

Validity and Reliability of the Videoconference-Based Berg Balance Scale in Stroke Survivors: The Tele-Berg Balance Scale.

Background And Purpose: Telerehabilitation represents an alternative for individuals who have difficulty accessing services to receive care. Therefore, telerehabilitation measures must be studied for their reliability and validity. This study evaluated the validity and reliability of the videoconference-based Berg Balance Scale assessment in stroke survivors.

Rare Causes and Differential Diagnosis in Patients With Silver-Russell Syndrome.

Silver-Russell syndrome (SRS) is an imprinting disorder mainly characterized by pre- and postnatal growth restriction. Most SRS cases are due to 11p15.5 loss of methylation (11p15.

Response to Recombinant Human Growth Hormone Therapy in Short Children Born at Very Low Birth Weight.

Introduction: Although the clinical benefits of long-term recombinant human growth hormone (rhGH) therapy have been well demonstrated in children born small for gestational age (SGA), little is known about the outcomes of this therapy in children born with very low birth weight (VLBW). This study aimed to report the short- and long-term response to rhGH therapy in a cohort of VLBW patients, comparing subgroups according to size, gestational age (GA), and causal factors associated with VLBW.

Methods: We describe 33 patients born at VLBW treated with rhGH; 16 also received GnRHa.